{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:16:21Z","timestamp":1790392581904,"version":"4.1.0"},"reference-count":74,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T00:00:00Z","timestamp":1360108800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0055091","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T22:39:46Z","timestamp":1360190386000},"page":"e55091","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":57,"title":["Long-Term Treatment of Thalidomide Ameliorates Amyloid-Like Pathology through Inhibition of \u03b2-Secretase in a Mouse Model of Alzheimer\u2019s Disease"],"prefix":"10.1371","volume":"8","author":[{"given":"Ping","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Staufenbiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rena","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,2,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation","volume":"177","author":"AL Moreira","year":"1993","journal-title":"J Exp Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes","volume":"173","author":"EP Sampaio","year":"1991","journal-title":"J Exp Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.biocel.2007.01.022","article-title":"The thalidomide saga","volume":"39","author":"M Melchert","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.47276\/lr.78.3.197","article-title":"The role of thalidomide in the management of erythema nodosum leprosum","volume":"78","author":"SL Walker","year":"2007","journal-title":"Lepr Rev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.biopha.2012.05.001","article-title":"Novel thalidomide analogues from diamines inhibit pro-inflammatory cytokine production and CD80 expression while enhancing IL-10","volume":"66","author":"L Mazzoccoli","year":"2012","journal-title":"Biomed Pharmacother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/B978-0-12-397927-8.00006-3","article-title":"Emerging strategies for targeting cell adhesion in multiple myeloma","volume":"65","author":"RR Nair","year":"2012","journal-title":"Adv Pharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.2003.03.139","article-title":"Thalidomide alone or with dexamethasone for previously untreated multiple myeloma","volume":"21","author":"D Weber","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/157489207780832478","article-title":"Thalidomide analogues as anticancer drugs","volume":"2","author":"JB Aragon-Ching","year":"2007","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1749-6632.2008.03972.x","article-title":"The role of neuroimmunomodulation in Alzheimer\u2019s disease","volume":"1153","author":"RB Maccioni","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1742-2094-2-23","article-title":"Early correlation of microglial activation with enhanced tumor necrosis factor-alpha and monocyte chemoattractant protein-1 expression specifically within the entorhinal cortex of triple transgenic Alzheimer\u2019s disease mice","volume":"2","author":"MC Janelsins","year":"2005","journal-title":"J Neuroinflammation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1073\/pnas.86.16.6348","article-title":"Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus","volume":"86","author":"AP Lieberman","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.2353\/ajpath.2008.080528","article-title":"Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3\u00d7Tg-AD mice","volume":"173","author":"MC Janelsins","year":"2008","journal-title":"Am J Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.neurobiolaging.2006.02.012","article-title":"Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease","volume":"28","author":"A Alvarez","year":"2007","journal-title":"Neurobiol Aging"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0531-5565(01)00191-7","article-title":"Proinflammatory cytokines in sera of elderly patients with dementia: levels in vascular injury are higher than those of mild-moderate Alzheimer\u2019s disease patients","volume":"37","author":"R Paganelli","year":"2002","journal-title":"Exp Gerontol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"H Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/jnnp.74.9.1200","article-title":"Intrathecal inflammation precedes development of Alzheimer\u2019s disease","volume":"74","author":"E Tarkowski","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1742-2094-2-9","article-title":"Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer\u2019s disease","volume":"2","author":"NS Patel","year":"2005","journal-title":"J Neuroinflammation"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0736-5748(00)00012-5","article-title":"Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology","volume":"18","author":"G Mehlhorn","year":"2000","journal-title":"Int J Dev Neurosci"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0361-9230(01)00730-4","article-title":"Endogenous brain cytokine mRNA and inflammatory responses to lipopolysaccharide are elevated in the Tg2576 transgenic mouse model of Alzheimer\u2019s disease","volume":"56","author":"LM Sly","year":"2001","journal-title":"Brain Res Bull"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1471-4159.2003.01837.x","article-title":"Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology","volume":"86","author":"G Munch","year":"2003","journal-title":"J Neurochem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(00)04008-3","article-title":"Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer\u2019s disease and vascular dementia: a case-control study","volume":"357","author":"SM McCusker","year":"2001","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3233\/JAD-2010-1253","article-title":"Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer\u2019s disease and non-demented patients","volume":"19","author":"X Cheng","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/187152711794653751","article-title":"Targeting TNF-alpha to elucidate and ameliorate neuroinflammation in neurodegenerative diseases","volume":"10","author":"KA Frankola","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.molmed.2006.10.002","article-title":"Distinct destructive signal pathways of neuronal death in Alzheimer\u2019s disease","volume":"12","author":"Y Shen","year":"2006","journal-title":"Trends Mol Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2009.01.006","article-title":"Inhibition of soluble TNF signaling in a mouse model of Alzheimer\u2019s disease prevents pre-plaque amyloid-associated neuropathology","volume":"34","author":"FE McAlpine","year":"2009","journal-title":"Neurobiol Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1742-2094-9-106","article-title":"Tumor necrosis factor-alpha synthesis inhibitor 3,6\u2032-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer\u2019s disease","volume":"9","author":"D Tweedie","year":"2012","journal-title":"J Neuroinflammation"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1742-2094-9-99","article-title":"Early intervention with a small molecule inhibitor for tumor necrosis factor-alpha prevents cognitive deficits in a triple transgenic mouse model of Alzheimer\u2019s disease","volume":"9","author":"SP Gabbita","year":"2012","journal-title":"J Neuroinflammation"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1083\/jcb.200705042","article-title":"Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer\u2019s mice","volume":"178","author":"P He","year":"2007","journal-title":"J Cell Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","article-title":"Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology","volume":"94","author":"C Sturchler-Pierrat","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Sommer B, Staufenbiel M (1998) A beta peptide deposition in the brains of transgenic mice: evidence for a key event in Alzheimer\u2019s disease pathogenesis. Mol Psychiatry 3: 284\u2013286, 282\u2013283.","DOI":"10.1038\/sj.mp.4000403"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.nbd.2007.08.019","article-title":"Thalidomide inhibition of perturbed vasculature and glial-derived tumor necrosis factor-alpha in an animal model of inflamed Alzheimer\u2019s disease brain","volume":"29","author":"JK Ryu","year":"2008","journal-title":"Neurobiol Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1006\/exer.1997.0292","article-title":"Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization","volume":"64","author":"BM Kenyon","year":"1997","journal-title":"Exp Eye Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/jso.20289","article-title":"Effect of thalidomide on colorectal cancer liver metastases in CBA mice","volume":"91","author":"J Daruwalla","year":"2005","journal-title":"J Surg Oncol"},{"key":"ref34","first-page":"1651","article-title":"Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma","volume":"23","author":"S Kaicker","year":"2003","journal-title":"Int J Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1523\/JNEUROSCI.0421-09.2009","article-title":"Interruption of beta-catenin signaling reduces neurogenesis in Alzheimer\u2019s disease","volume":"29","author":"P He","year":"2009","journal-title":"J Neurosci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF03401867","article-title":"The evolution of A beta peptide burden in the APP23 transgenic mice: implications for A beta deposition in Alzheimer disease","volume":"7","author":"YM Kuo","year":"2001","journal-title":"Mol Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0002-9440(10)64085-0","article-title":"Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease","volume":"158","author":"Y Matsuoka","year":"2001","journal-title":"Am J Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2006.08.001","article-title":"Congo red and protein aggregation in neurodegenerative diseases","volume":"53","author":"P Frid","year":"2007","journal-title":"Brain Res Rev"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","article-title":"Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer\u2019s disease","volume":"23","author":"Q Yan","year":"2003","journal-title":"J Neurosci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1523\/JNEUROSCI.1090-04.2004","article-title":"Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition","volume":"24","author":"DM Wilcock","year":"2004","journal-title":"J Neurosci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.neuron.2006.01.022","article-title":"Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer\u2019s disease","volume":"49","author":"AR Simard","year":"2006","journal-title":"Neuron"},{"key":"ref42","first-page":"274","article-title":"Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol","volume":"309","year":"1999"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"R Vassar","year":"1999","journal-title":"Science"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2353\/ajpath.2006.050752","article-title":"Neuronal or glial expression of human apolipoprotein e4 affects parenchymal and vascular amyloid pathology differentially in different brain regions of double- and triple-transgenic mice","volume":"168","author":"T Van Dooren","year":"2006","journal-title":"Am J Pathol"},{"key":"ref45","first-page":"1121","article-title":"The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease","volume":"115","author":"S Gandy","year":"2005","journal-title":"J Clin Invest"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics","volume":"297","author":"J Hardy","year":"2002","journal-title":"Science"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrn2494","article-title":"Thirty years of Alzheimer\u2019s disease genetics: the implications of systematic meta-analyses","volume":"9","author":"L Bertram","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/990114","article-title":"Purification and cloning of amyloid precursor protein beta-secretase from human brain","volume":"402","author":"S Sinha","year":"1999","journal-title":"Nature"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/mcne.1999.0811","article-title":"Identification of a novel aspartic protease (Asp 2) as beta-secretase","volume":"14","author":"I Hussain","year":"1999","journal-title":"Mol Cell Neurosci"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/990107","article-title":"Membrane-anchored aspartyl protease with Alzheimer\u2019s disease beta-secretase activity","volume":"402","author":"R Yan","year":"1999","journal-title":"Nature"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1073\/pnas.97.4.1456","article-title":"Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein","volume":"97","author":"X Lin","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1073\/pnas.0205689101","article-title":"Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer\u2019s disease patients","volume":"101","author":"R Li","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nm0103-3","article-title":"Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease","volume":"9","author":"LB Yang","year":"2003","journal-title":"Nat Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nm.2460","article-title":"Resolving controversies on the path to Alzheimer\u2019s therapeutics","volume":"17","author":"DJ Selkoe","year":"2011","journal-title":"Nat Med"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1750-1326-2-15","article-title":"An AICD-based functional screen to identify APP metabolism regulators","volume":"2","author":"C Zhang","year":"2007","journal-title":"Mol Neurodegener"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1007\/s00018-008-8112-4","article-title":"Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin","volume":"65","author":"E Malito","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer\u2019s disease","volume":"183","author":"MI Fonseca","year":"2009","journal-title":"J Immunol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nn.2583","article-title":"Amyloid-beta-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks","volume":"13","author":"JJ Palop","year":"2010","journal-title":"Nat Neurosci"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"29621","DOI":"10.1074\/jbc.R800015200","article-title":"The role of amyloid precursor protein processing by BACE1, the beta-secretase, in Alzheimer disease pathophysiology","volume":"283","author":"SL Cole","year":"2008","journal-title":"J Biol Chem"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archneur.59.9.1381","article-title":"Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease","volume":"59","author":"H Fukumoto","year":"2002","journal-title":"Arch Neurol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.10208","article-title":"Increased expression of the amyloid precursor beta-secretase in Alzheimer\u2019s disease","volume":"51","author":"RM Holsinger","year":"2002","journal-title":"Ann Neurol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0002-9440(10)63159-8","article-title":"Beta-secretase activity increases with aging in human, monkey, and mouse brain","volume":"164","author":"H Fukumoto","year":"2004","journal-title":"Am J Pathol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0006-291X(03)01270-1","article-title":"Interferon gamma stimulates beta-secretase expression and sAPPbeta production in astrocytes","volume":"307","author":"HS Hong","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"ref64","first-page":"BR357","article-title":"Morphine via nitric oxide modulates beta-amyloid metabolism: a novel protective mechanism for Alzheimer\u2019s disease","volume":"11","author":"T Pak","year":"2005","journal-title":"Med Sci Monit"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/nbdi.2002.0515","article-title":"Oxidative stress increases expression and activity of BACE in NT2 neurons","volume":"10","author":"E Tamagno","year":"2002","journal-title":"Neurobiol Dis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1523\/JNEUROSCI.22-08-03025.2002","article-title":"Target depletion of distinct tumor necrosis factor receptor subtypes reveals hippocampal neuron death and survival through different signal transduction pathways","volume":"22","author":"L Yang","year":"2002","journal-title":"J Neurosci"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cell.2005.02.008","article-title":"Twenty years of the Alzheimer\u2019s disease amyloid hypothesis: a genetic perspective","volume":"120","author":"RE Tanzi","year":"2005","journal-title":"Cell"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jmb.2010.10.054","article-title":"Inhibiting beta-secretase activity in Alzheimer\u2019s disease cell models with single-chain antibodies specifically targeting APP","volume":"405","author":"S Boddapati","year":"2011","journal-title":"J Mol Biol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/emmm.201101084","article-title":"beta-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment","volume":"4","author":"J Cai","year":"2012","journal-title":"EMBO Mol Med"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1523\/JNEUROSCI.5253-05.2006","article-title":"Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"26","author":"M Kiaei","year":"2006","journal-title":"J Neurosci"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1073\/pnas.1037392100","article-title":"Gamma-secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2","volume":"100","author":"WT Kimberly","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2007.12.014","article-title":"Restraining tumor necrosis factor-alpha by thalidomide prevents the amyloid beta-induced impairment of recognition memory in mice","volume":"189","author":"T Alkam","year":"2008","journal-title":"Behav Brain Res"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2174\/156720507781788873","article-title":"TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets","volume":"4","author":"D Tweedie","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Sabbagh MN, Nural F, He P, Sirrel S, Belden C, <etal>et al<\/etal>.. (2010) Rationale and strategy for thalidomide as a BACE 1 inhibitor for a phase II randomized clinical trial in mild-to-moderate Alzheimer\u2019s disease. Alzheimers Dementia 6.","DOI":"10.1016\/j.jalz.2010.05.1996"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0055091","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T22:53:23Z","timestamp":1644274403000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0055091"}},"subtitle":[],"editor":[{"given":"Zhongcong","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,6]]},"references-count":74,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0055091","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,6]]}}}